CSIMarket


Inari Medical Inc   (NARI)
Other Ticker:  
 


 

Inari Medical Inc

NARI's Financial Statements and Analysis



Inari Medical Inc increased first quarter of 2024 net loss per share of $-0.42 compare to net loss per share of $-0.04 recorded in the same quarter a year ago a decrease compare to $-0.08 realized in previous quarter.


first quarter of 2024
Earnings Per Share Revenues
$ -0.42 $  142 Mill
$-0.38     $+26M     +22.5 %



Inari Medical Inc 's Revenue rose by 22.5 % in first quarter of 2024 (Mar 31 2024) year on year, to $142 million and advanced by 7.39 % sequentially.


Inari Medical Inc is

More on NARI's Income Statement



Inari Medical Inc in the first quarter of 2024 recorded net loss of $-24.202 million, an increase from net loss of $-2.218 million in I. Quarter a year ago.

Sequentially net loss advanced

More on NARI's Growth

Inari Medical Inc Inventories
Inventories grew by 22.33 % to $45 million from I. Quarter a year ago, sequentially inventories rose by 4.08 %. NARI's Cash flow In the first quarter of 2024 company's net cash flow was $28 million, capital expenditures fell by -0.96498.13%, to $-2 millions compare to same quarter a year ago

More on NARI's Cash flow Statement


Inari Medical Inc does not pay out common stock dividend.

In trailing twelve-month period Inari Medical Inc earned $ 0.44 cash per share, on a free-cash flow basis .

Book value fell by -9.46 % sequentially to $7.72 per share, -197.92% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 1.58 per share from $ 1.83.

Company issued 3.40 million shares or 6.24 % in Mar 31 2024.


More on NARI's Dividends

 Market Capitalization (Millions) 2,762
 Shares Outstanding (Millions) 58
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 520
 Net Income (TTM) (Millions $) -24
 Cash Flow (TTM) (Millions $) 11
 Capital Exp. (TTM) (Millions $) -7
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 450




Inari Medical Inc does not pay out common stock dividend.

In trailing twelve-month period Inari Medical Inc had $ 0.44 cash flow per share, on a free-cash flow basis .

Book value fell by -9.46 % sequentially to $7.72 per share, -197.92% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 1.58 per share from $ 1.83.

Company issued 3.40 million shares or 6.24 % in Mar 31 2024.


More on NARI's Balance Sheets

 Market Capitalization (Millions) 2,762
 Shares Outstanding (Millions) 58
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 520
 Net Income (TTM) (Millions $) -24
 Cash Flow (TTM) (Millions $) 11
 Capital Exp. (TTM) (Millions $) -7
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 450
   


  News about Inari Medical Inc Earnings

Stock Price Decline Raises Concerns Despite Revenue Surge at Inari Medical Inc.



Inari Medical Inc. (NASDAQ: NARI) recently announced its financial results for the first quarter of 2024, which demonstrated a remarkable surge in revenue by 22.497% to $142.30 million from the corresponding period a year prior. However, despite hitting a revenue milestone, the company struggled with an increased deficit per share at $-0.42. As the medical equipment and supplies sector experienced a 9.75% top-line growth, it is evident that Inari Medical Inc. has outperformed its peers in terms of revenue. Nevertheless, the company's stock price declined significantly in recent months, raising concerns among investors.
Revenue Growth and Comparisons:
Inari Medical Inc.'s revenue growth is a...

Inari Medical Inc. Celebrates Record Revenue Surge in Fourth Quarter of 2023 Earnings Season

Inari Medical Inc, a leading medical device company, recently announced a significant surge in revenue for the fourth quarter of 2023. Despite reporting a net loss of $-0.08 per share, the company's revenue increased by an impressive 22.949% to $132.50 million compared to the same period the year before. This revenue surge outperformed the average top-line elevation of 7.86% seen in the Medical Equipment and Supplies sector.
Although the company experienced a decrease in earnings per share compared to the previous quarter, with EPS falling to $-0.03 from $-0.55 in the prior fiscal year, their revenue continued to improve. Inari Medical reported a net loss of $-4.665 million in the fourth quarter of 2023,...

Examining the Concerning Factors and Potential Risks behind Inari Medical Inc's Positive Financial Results



Inari Medical Inc, a prominent player in the Medical Equipment and Supplies industry, recently reported positive financial results for its most recent fiscal period. While these results may appear encouraging at first glance, a closer examination reveals concerning indicators and potential risks for the company. This article aims to present a bearish perspective on Inari Medical Inc based on several key factors.
1. Stagnating Business Growth
While Inari Medical Inc has showcased positive growth in profits, it is essential to consider the broader industry context. In the third quarter of 2023, when compared to the same quarter the previous year, the overall Medical Equipment and Supplies ind...

Inari Medical Inc Announces Impressive Surge in Q2 2023 Revenues, Turning Profitable with 28.316% Growth



Inari Medical Inc, a leading player in the Medical Equipment and Supplies industry, has recently reported impressive financial results for the second quarter of 2023. The company's revenue surged by an astonishing 28.316% to reach $119.01 million, marking a significant turnaround for the company as it shifted from losses to profitability. This remarkable achievement can be attributed to various factors, including increased demand and a positive shift in earnings per share (EPS).
Revenue Growth:
During the second quarter of 2023, Inari Medical outperformed its industry peers, recording a 28.316% revenue growth. In comparison, the average revenue growth for the Medical Equipment and Supplies ...

Inari Medical Inc. Achieves Astonishing Revenue Jump of 33.9% to Reach $116.17 Million in Q1 2023

Inari Medical Inc, a medical technology company that develops innovative solutions for the treatment of venous diseases, has reported significant improvements in its financial performance for the fiscal interval closing March 31, 2023. The company has reduced its loss per share to $-0.04 per share, compared to $-0.06 per share a year earlier. Moreover, its earnings per share (EPS) have improved from $-0.10 per share in the prior reporting period.
One of the most notable changes, however, is the company's revenue jump of 33.907% to reach $116.17 million compared to $86.75 million in the corresponding reporting period a year ago. Moreover, the revenue has advanced sequentially by 7.791%, up from $107.77 mi...


Date modified: 2024-05-01T12:25:20+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com